Question 1

What is the catalog number for Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803?

Accepted Answer

The catalog number for Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803 is LY803.

Question 2

Is Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803 in stock?

Accepted Answer

Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803 used for?

Accepted Answer

Lymph node metastatic adenocarcinoma (grade 2-3) tissue microarray of lymph node, 77 cases and 3 cases of metastatic signet-ring cell carcinoma, single core per case

Question 4

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803

Product Specifications

Sample Type

Cases

Cores

Frequently Asked Questions

Explore Other Products

Spectrin beta I (SPTB) (RG/26), CF405S conjugate, 0.1mg/mL

Anti-C5/C5a Antibody Picoband®, iFluor647 Conjugate

TACSTD2 / TROP2 (Epithelial Marker) (TACSTD2/2151), CF488A conjugate, 0.1mg/mL

CD4 (T-Helper/Inducer Cell Marker) (RIV7), 0.2mg/mL

Aldo-keto Reductase Family 1 Member C2 / DD2 (CPTC-AKR1C2-1), CF594 conjugate, 0.1mg/mL

CD45 / LCA (136-4B5), 0.2mg/mL